Cargando…

Small-cell lung cancer in never-smokers

BACKGROUND: Lung cancer is a public health problem worldwide. Small-cell lung cancer (SCLC) is the most aggressive histologic type, with a 5-year survival <10%. SCLC is closely associated with tobacco consumption and infrequent in never-smokers. We aim to describe SCLC characteristics in never-sm...

Descripción completa

Detalles Bibliográficos
Autores principales: Torres-Durán, M., Curiel-García, M.T., Ruano-Ravina, A., Provencio, M., Parente-Lamelas, I., Hernández-Hernández, J., Fernández-Villar, A., Barros-Dios, J.M., Pérez-Ríos, M.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7920829/
https://www.ncbi.nlm.nih.gov/pubmed/33640828
http://dx.doi.org/10.1016/j.esmoop.2021.100059
_version_ 1783658360160124928
author Torres-Durán, M.
Curiel-García, M.T.
Ruano-Ravina, A.
Provencio, M.
Parente-Lamelas, I.
Hernández-Hernández, J.
Fernández-Villar, A.
Barros-Dios, J.M.
Pérez-Ríos, M.
author_facet Torres-Durán, M.
Curiel-García, M.T.
Ruano-Ravina, A.
Provencio, M.
Parente-Lamelas, I.
Hernández-Hernández, J.
Fernández-Villar, A.
Barros-Dios, J.M.
Pérez-Ríos, M.
author_sort Torres-Durán, M.
collection PubMed
description BACKGROUND: Lung cancer is a public health problem worldwide. Small-cell lung cancer (SCLC) is the most aggressive histologic type, with a 5-year survival <10%. SCLC is closely associated with tobacco consumption and infrequent in never-smokers. We aim to describe SCLC characteristics in never-smokers recruited in a radon-prone area. PATIENTS AND METHODS: We designed a multicentric case series where SCLC cases were recruited consecutively following histologic confirmation. Detailed information was obtained for indoor radon exposure, occupation and environmental tobacco smoke. We also collected different clinical characteristics such as extended or limited disease at diagnosis. RESULTS: We recruited 32 never-smoking SCLC cases. Median age was 75 years and 87.5% were women; 47% had extended disease. Median radon concentration was 182 Bq/m(3). There were no statistically significant differences in residential radon concentration neither regarding age at diagnosis nor regarding sex. The most frequent symptoms were constitutional syndrome (23.1%) and coughing (23.1%). As much as 63% of cases had an Eastern Cooperative Oncology Group Study (ECOG) status of 0-2. The 1- and 2-year survival rates were 34.4% and 21.9%, respectively. The 2-year survival rate with a localized tumor was 26.7%, compared with 18.8% for extended disease. CONCLUSIONS: These results show, for the first time, that indoor radon might not be associated with SCLC characteristics at diagnosis in never-smokers, and also confirms the low survival of this aggressive type of lung cancer also for never-smokers.
format Online
Article
Text
id pubmed-7920829
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher Elsevier
record_format MEDLINE/PubMed
spelling pubmed-79208292021-03-12 Small-cell lung cancer in never-smokers Torres-Durán, M. Curiel-García, M.T. Ruano-Ravina, A. Provencio, M. Parente-Lamelas, I. Hernández-Hernández, J. Fernández-Villar, A. Barros-Dios, J.M. Pérez-Ríos, M. ESMO Open Original Research BACKGROUND: Lung cancer is a public health problem worldwide. Small-cell lung cancer (SCLC) is the most aggressive histologic type, with a 5-year survival <10%. SCLC is closely associated with tobacco consumption and infrequent in never-smokers. We aim to describe SCLC characteristics in never-smokers recruited in a radon-prone area. PATIENTS AND METHODS: We designed a multicentric case series where SCLC cases were recruited consecutively following histologic confirmation. Detailed information was obtained for indoor radon exposure, occupation and environmental tobacco smoke. We also collected different clinical characteristics such as extended or limited disease at diagnosis. RESULTS: We recruited 32 never-smoking SCLC cases. Median age was 75 years and 87.5% were women; 47% had extended disease. Median radon concentration was 182 Bq/m(3). There were no statistically significant differences in residential radon concentration neither regarding age at diagnosis nor regarding sex. The most frequent symptoms were constitutional syndrome (23.1%) and coughing (23.1%). As much as 63% of cases had an Eastern Cooperative Oncology Group Study (ECOG) status of 0-2. The 1- and 2-year survival rates were 34.4% and 21.9%, respectively. The 2-year survival rate with a localized tumor was 26.7%, compared with 18.8% for extended disease. CONCLUSIONS: These results show, for the first time, that indoor radon might not be associated with SCLC characteristics at diagnosis in never-smokers, and also confirms the low survival of this aggressive type of lung cancer also for never-smokers. Elsevier 2021-02-26 /pmc/articles/PMC7920829/ /pubmed/33640828 http://dx.doi.org/10.1016/j.esmoop.2021.100059 Text en © 2021 The Author(s) http://creativecommons.org/licenses/by-nc-nd/4.0/ This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
spellingShingle Original Research
Torres-Durán, M.
Curiel-García, M.T.
Ruano-Ravina, A.
Provencio, M.
Parente-Lamelas, I.
Hernández-Hernández, J.
Fernández-Villar, A.
Barros-Dios, J.M.
Pérez-Ríos, M.
Small-cell lung cancer in never-smokers
title Small-cell lung cancer in never-smokers
title_full Small-cell lung cancer in never-smokers
title_fullStr Small-cell lung cancer in never-smokers
title_full_unstemmed Small-cell lung cancer in never-smokers
title_short Small-cell lung cancer in never-smokers
title_sort small-cell lung cancer in never-smokers
topic Original Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7920829/
https://www.ncbi.nlm.nih.gov/pubmed/33640828
http://dx.doi.org/10.1016/j.esmoop.2021.100059
work_keys_str_mv AT torresduranm smallcelllungcancerinneversmokers
AT curielgarciamt smallcelllungcancerinneversmokers
AT ruanoravinaa smallcelllungcancerinneversmokers
AT provenciom smallcelllungcancerinneversmokers
AT parentelamelasi smallcelllungcancerinneversmokers
AT hernandezhernandezj smallcelllungcancerinneversmokers
AT fernandezvillara smallcelllungcancerinneversmokers
AT barrosdiosjm smallcelllungcancerinneversmokers
AT perezriosm smallcelllungcancerinneversmokers